Phase II evaluation of early oral estramustine, oral etoposide and intravenous paclitaxel in patients with hormonally responsive adenocarcinoma of the prostate
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Estramustine; Etoposide; Paclitaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 21 Jan 2015 Biomarkers information updated
- 23 Oct 2005 New trial record.